Abstract
Background: Cathepsin S deletion was shown to induce a robust reduction in blood sugar in knockout mice, whereas cystatin C is the most abundant and potent endogenous inhibitor of cathepsin S. We explored the roles of cystatin C and cathepsin S in patients with type 2 diabetes mellitus (T2DM) receiving either gastric bypass (GB) or sleeve gastrectomy (SG).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
